DK1057828T3 - Orale trovafloxacin-suspensioner - Google Patents

Orale trovafloxacin-suspensioner

Info

Publication number
DK1057828T3
DK1057828T3 DK00304550T DK00304550T DK1057828T3 DK 1057828 T3 DK1057828 T3 DK 1057828T3 DK 00304550 T DK00304550 T DK 00304550T DK 00304550 T DK00304550 T DK 00304550T DK 1057828 T3 DK1057828 T3 DK 1057828T3
Authority
DK
Denmark
Prior art keywords
suspensions
crystals
trovafloxacin
oral
novel
Prior art date
Application number
DK00304550T
Other languages
Danish (da)
English (en)
Inventor
Douglas John Meldrum Pfi Allen
Sojka Sonja Pfizer Cen Sekulic
Daniel Ray Pfizer Cent Arenson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1057828T3 publication Critical patent/DK1057828T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
DK00304550T 1999-06-04 2000-05-30 Orale trovafloxacin-suspensioner DK1057828T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13746399P 1999-06-04 1999-06-04

Publications (1)

Publication Number Publication Date
DK1057828T3 true DK1057828T3 (da) 2003-07-14

Family

ID=22477550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00304550T DK1057828T3 (da) 1999-06-04 2000-05-30 Orale trovafloxacin-suspensioner

Country Status (10)

Country Link
US (1) US6239141B1 (pt)
EP (1) EP1057828B1 (pt)
JP (1) JP3465820B2 (pt)
AT (1) ATE234835T1 (pt)
BR (1) BR0002577A (pt)
CA (1) CA2311112A1 (pt)
DE (1) DE60001687T2 (pt)
DK (1) DK1057828T3 (pt)
ES (1) ES2194677T3 (pt)
PT (1) PT1057828E (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4803935B2 (ja) 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Ｆａｂｉ阻害剤
CA2440412A1 (en) * 2001-03-05 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Taste masked liquid pharmaceutical compositions
ATE420640T1 (de) * 2001-04-06 2009-01-15 Affinium Pharm Inc Fab-i-inhibitoren
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
WO2003006441A1 (en) * 2001-07-10 2003-01-23 Pharmacia & Upjohn Company Crystalline thiazine oxazolidinones
CA2455050C (en) * 2001-08-15 2007-02-20 Pharmacia & Upjohn Company Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
US8367098B2 (en) * 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
US7790709B2 (en) * 2002-12-06 2010-09-07 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
CA2519429C (en) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
DK1828167T3 (da) 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
CA2658506C (en) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
NZ702695A (en) 2012-06-19 2015-10-30 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
PT3419628T (pt) 2016-02-26 2021-01-05 Debiopharm Int Sa Medicamento para o tratamento de infeções do pé diabético

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5266559A (en) 1989-10-27 1993-11-30 Firmenich S.A. Use of unsaturated macrocyclic lactones as perfuming ingredients
US5391763A (en) 1990-07-11 1995-02-21 Pfizer Inc. 3-aza-bicyclo[3.1.0]hexanes which are intermediates for anti-bacterial azabicyclo quinolone carboxylic acids
TW271400B (pt) 1992-07-30 1996-03-01 Pfizer
EP0789697B1 (en) 1995-06-06 1998-06-17 Pfizer Inc. CRYSTAL FORM OF ANHYDROUS 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1. 0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
IL122652A (en) * 1995-08-29 2000-01-31 Pfizer Polymorphs of the pro drug 6-n-(l-ala-l-ala)- trovafloxacin their preparation and pharmaceutical compositions containing them
WO1997007800A1 (en) 1995-08-29 1997-03-06 Pfizer Inc. Zwitterionic forms of trovafloxacin
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids

Also Published As

Publication number Publication date
JP2000344770A (ja) 2000-12-12
BR0002577A (pt) 2001-01-02
EP1057828A3 (en) 2001-05-16
CA2311112A1 (en) 2000-12-04
US6239141B1 (en) 2001-05-29
JP3465820B2 (ja) 2003-11-10
DE60001687T2 (de) 2003-12-18
EP1057828A2 (en) 2000-12-06
ATE234835T1 (de) 2003-04-15
PT1057828E (pt) 2003-07-31
ES2194677T3 (es) 2003-12-01
EP1057828B1 (en) 2003-03-19
DE60001687D1 (de) 2003-04-24

Similar Documents

Publication Publication Date Title
DK1057828T3 (da) Orale trovafloxacin-suspensioner
IL165715A0 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
EA199901014A1 (ru) C-4"-замещенные макролидные производные
CY1111693T1 (el) Αντιιικοι παραγοντες
WO2003064431A3 (en) Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
BG101118A (en) Therapeutical compounds
CA2292359A1 (en) Novel azalides and methods of making same
YU41500A (sh) Novi makrolidi
MXPA04012965A (es) Inhibidores virales.
DK1200412T3 (da) Antiproliferative imidazolforbindelser
NO996108L (no) 9-oksinerytromycinderivater
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
TR200102128T2 (tr) Ketolid antibiyotikler
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
GT199900208A (es) Antibiòticos cetòlidos carbamato y carbazato.
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
DE60208404D1 (de) Kreuzverquerte glycopeptid-cephalosporin-antibiotika
DE69917717D1 (de) C11-Carbamate von antibakteriellen Makroliden
AP9801377A0 (en) Tricyclic erythromycin derivatives.
AP9801235A0 (en) Erythromycin derivatives.
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
ATE286728T1 (de) Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen
BR9902049A (pt) Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina.
GB9926301D0 (en) Novel compounds